Vera Therapeutics Inc.

01/30/2023 | Press release | Distributed by Public on 01/30/2023 05:11

Vera Therapeutics Releases 36 Week Interim Analysis of Phase 2b Clinical Trial of Atacicept for the Treatment of IgA Nephropathy; Patients in the 150 mg Dose Group Achieved a[...]